Capital International Investors Biomarin Pharmaceutical Inc Transaction History

Capital International Investors

$475 Billion
Q2 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$74.28 - $92.69 $287,017 - $358,154	-3,864 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $39 Million - $49.8 Million	-543,937 Reduced 99.29%	3,864 $344,000
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $18,094 - $20,683	-242 Reduced 0.04%	547,801 $42.3 Million
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $83,212 - $93,438	1,102 Added 0.2%	548,043 $45.7 Million
Q1 2021 May 14, 2021	BUY	$74.73 - $90.69 $20,924 - $25,393	280 Added 0.05%	546,941 $41.3 Million
Q4 2020 Feb 12, 2021	BUY	$72.61 - $90.2 $67,962 - $84,427	936 Added 0.17%	546,661 $47.9 Million
Q3 2020 Nov 13, 2020	SELL	$71.87 - $131.03 $30.9 Million - $56.3 Million	-429,601 Reduced 44.05%	545,725 $41.5 Million
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $142,951 - $223,223	1,797 Added 0.18%	975,326 $120 Million
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $114 Million - $154 Million	-1,593,708 Reduced 62.08%	973,529 $82.3 Million
Q4 2019 Feb 18, 2020	BUY	$64.27 - $86.37 $93,448 - $125,581	1,454 Added 0.06%	2,567,237 $217 Million
Q3 2019 Nov 14, 2019	BUY	$67.4 - $85.11 $51.5 Million - $65 Million	764,300 Added 42.43%	2,565,783 $173 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $1.98 Million - $2.32 Million	24,664 Added 1.39%	1,801,483 $154 Million
Q1 2019 May 15, 2019	SELL	$84.2 - $98.62 $138 Million - $161 Million	-1,635,825 Reduced 47.93%	1,776,819 $158 Million
Q4 2018 Feb 14, 2019	BUY	$80.14 - $106.07 $105 Million - $139 Million	1,308,641 Added 62.2%	3,412,644 $291 Million
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $198 Million - $222 Million	2,104,003 New	2,104,003 $204 Million

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

Black Rock Inc. New York, NY

22.7M
Shares

$1.6 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$1.34 Billion
0.03% of portfolio
Primecap Management CO Pasadena, CA

18.8M
Shares

$1.33 Billion
1.14% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$983 Million
0.72% of portfolio
Capital Research Global Investors Los Angeles, CA

9.69M
Shares

$684 Million
0.18% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.

Account